Evidence for the involvement of ecto-5'-nucleotidase (CD73) in drug resistance

International Journal of Cancer

Volumn 68, Issue 4, 1996, Pages 493-500

  Ujházy, Peter ^a,b   Berleth, Erica S ^a   Pietkiewicz, Joelle M ^a   Kitano, Haruhisa ^a   Skaar, Jeffrey R ^a   Ehrke, M Jane ^a   Mihich, Enrico ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Biotech Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' NUCLEOTIDASE; ADENOSINE; ALPHA,BETA METHYLENEADENOSINE DIPHOSPHATE; DOXORUBICIN; ECTO 5' NUCLEOTIDASE; MESSENGER RNA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL LINE;

5'-NUCLEOTIDASE; ADENOSINE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ANIMALS; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; HUMANS; MICE; RHODAMINES; RNA, MESSENGER; TUMOR CELLS, CULTURED;

EID: 0029835821     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961115)68:4<493::AID-IJC15>3.0.CO;2-6     Document Type: Article

References (32)

1. ABRAHAM, E.H., PRAT, A.G., GERWECK, L., SENEVERATNE,T., ARCECT, R.J., KRAMER, R., GUIDOTTI, G. and CANTIELLO, H.F., The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. nat. Acad. Sci. (Wash.), 90, 312-316 (1993).
2. BHUSHAN, A., ABRAMSON, R., CHIU, J.F. and TRITTON, T.R., Expression of c-fos in human and murine multidrug-resistant cells. Mol. Pharmacol., 42, 69-74 (1992).
3. CHEN, H.X., BAMBERGER, U., HECKEL, A., GUO, X. and CHENG, Y.C., BIBW 22, a dipyridamole analogue, acts as a bifunctional modulator on tumor cells by influencing both P-glycoprotein and nucleoside transport. Cancer Res., 53, 1974-1977 (1993).
4. COLE, S.P., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line [see comments]. Science, 258, 1650-1654 (1992).
5. DICKSTEIN, B., VALVERIUS, E.M., WOSIKOWSKI, K., SACEDA, M., PEARSON, J.W., MARTIN, M.B. and BATES, S.E., Increased epidermal growth factor receptor in an estrogen-responsive, adriamycin-resistant MCF-7cell line. J. cell. Physiol., 157, 110-118 (1993).
6. HOUGHTON, J.A., HOUGHTON, P.J., HAZELTON, B.J. and DOUGLASS, E.C., In situ selection of a human rhabdomyosarcoma resistant to vincristine with altered beta-tubulins. Cancer Ris., 45, 2706-2712 (1985).
7. HOWELL, S.B., HOM, D., SANGA, R., VICK, J.S. and AHRAMSON, I.S., Comparison of the synergistic potentiation of etoposide, doxorubicin, and vinblastine cytotoxicity by dipyridamole. Cancer Res., 49, 3178-3183 (1989).
8. KARTNER, N., RIORDAN, J.R. and LING, V., Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science, 221, 1285-1288 (1983).
9. KRISHNAMACHARY, N. and CENTER, M.S., The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Res., 53, 3658-3661 (1993).
10. KRISHNAMACHARY, N., MA, L., ZHENG, L., SAFA, A.R. and CENTER, M.S., Analysis of MRP gene expression and function in HL60 cells isolated for resistance to adriamycin. Oncol. Res., 6, 119-127 (1994).
11. LYON, R.C., COHEN, J.S., FAUSTINO, P.J., MEGNIN, F. and MYERS, C.E., Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res., 48, 870-877 (1988).
12. MEHTA, K., High levels of transglutaminase expression in doxorubicin-resistant human breast carcinoma cells. Int. J. Cancer, 58, 400-406 (1994).
13. MIHICH, E. and BAKER, R.M., Molecular mechanisms of resistance to anticancer drugs. FORUM. Trends Exp. clin. Med., 4.3, 290-304 (1994).
14. MINDERMAN, H., BUSCAGLIA, M.D., WRZOSEK, C., BAHR, M.R. and RUSTUM, Y., CD34 and P-glycoprotein (Pgp) expression on multidrug resistant (mdr) human ovarian carcinoma cells [Abstract]. Proc. Amer. Assoc. Cancer Res., 35, A2055 (1994).
15. PATERSON, A.R., LAU, E.Y., DAHLIG, E. and CASS, C.E., A common basis for inhibition of nucleoside transport by dipyridamole and nitrobenzylthioinosine? Mol. Pharmacol., 18, 40-44 (1980).
16. POSADA, J.A., MCKEEGAN, E.M., WORTHINGTON, K.F., MORIN, M.J., JAKEN, S. and TRITTON, T.R., Human multidrug resistant KB cells overexpress protein kinase C: involvement in drug resistance. Cancer Comm., 1, 285-292 (1989).
17. RAMU, A., GLAUBIGER, D., SOPREY, P., REAMAN, G.H. and FEUERSTEIN, N., 5′-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells. Brit. J. Cancer, 49, 447-451 (1984).
18. REED, J.C., Bcl-2 and chemoresistance in cancer. Proc. Amer. Assoc. Cancer Res., 36, 711-712 (1995).
19. RESTA, R., HOOKER, S.W., HANSEN, K.R., LAURENT, A.B., PARK, J.L., BLACKBURN, M.R., KNUDSEN, T.B. and THOMPSON, L.F., Murine ecto-5′-nucleotidase (CD73): cDNA cloning and tissue distribution. Gene, 133, 171-177 (1993).
20. RITKE, M.K., BERGOLTZ, V.V., ALLAN, W.P. and YALOWICH, J.C., Increased c-jun/AP-1 levels in etoposide-resistant human leukemia K562 cells. Biochem. Pharmacol., 48, 525-533 (1994).
21. SAMPSON, K.E., MCCROSKEY, M.C. and ABRAHAM, I., Identification of a 170 kDa membrane kinase with increased activity in KB-V1 multidrug resistant cells. J cell. Biochem., 52, 384-395 (1993).
22. r 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479 (1993).
23. SCHEPER, R.J., DALTON, W.S., GROGAN, T.M., SCHLOSSER, A., BELLAMY, W.T., TAYLOR, C.W., SCUDERI, P. and SPIER, C., Altered expression of P-glycoprotein and cellular adhesion molecules on human multi-drug-resistant tumor cells does not affect their suscepti- bility to NK- and LAK-mediated cytotoxicity. Int. J. Cancer, 48, 562-567 (1991).
24. SCHLAIFER, D., COOPER, M.R., ATTAL, M., SARTOR, A.O., TREPEL, J.B., LAURENT, G. and MYERS, C.E., Myeloperoxidase: an enzyme involved in intrinsic vincristine resistance in human myeloblastic leukemia. Blood, 81, 482-489 (1993).
25. SRIDHAR, K.S., KRISHAN, A., UCAR, A., SAMY, T.S., ELIE-AUGUSTE, M., SAUERTEIG, A., MCPHEE, G., RAMACHANDRAN, C., BENEDETTO, P. and GARCIA, J., Phase 1 clinical and pharmacokinetic study of escalating doses of dipyridamole and a fixed dose of doxorubicin [Abstract]. Proc. Amer. Soc. clin. Oncol., 12, A456 (1993).
26. r 85,000 protein overexpressed in adriamycin-resistant human tumor cells. Cancer Res., 53, 2538-2543 (1993).
27. UHRÍK, B., TRIBULOVÁ, N., KLOBUŠICKÁ, M., BARANCÍK, M. and BREIER, A., Characterization of morphological and histochemical changes induced by overexpression of P-glycoprotein in mouse leukemic cell line L1210. Neoplasms, 41, 83-88 (1994).
28. UJHÁZY, P., BERLETH, E.S., PIETKIEWICZ, J.M., SKAAR, J.R., EHRKE, M.J. and MIHICH, E., Ecto-5′-nucleotidase in multidrug resistant cells: expression of mRNA and involvement in resistance [Abstract]. Proc. Amer. Assoc. Cancer Res., 36, A1936 (1995).
29. UJHÁZY, P., KITANO, H., EHRKE, M.J. and MIHICH, E., Reversal of resistance to doxorubicin in ecto-5′-nucleotidase positive cell lines by alpha,beta-methyleneadenosine 5′-diphosphate [Abstract]. Proc. Amer. Assoc. Cancer Res., 35, A2119 (1994a).
30. UJHÁZY, P., KLOBUŠICKá, M., BABUŠÍKOVÁ, O., STRAUSBAUCH, P., MIHICH, E. and EHRKE, M.J., Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin. Int. J. Cancer, 59, 83-93 (1994b).
31. YEH, G.C., OCCHIPINTI, S.J., COWAN, K.H., CHABNER, B.A. and MYERS, C.E., Adriamycin resistance in human tumor cells associated with marked alteration in regulation of the hexose monophosphate shunt and its response to oxidant stress. Cancer Res., 47, 5994-5999 (1987).
32. ZIMMERMANN, H., 5′-Nucleotidase: molecular structure and functional aspects. Biochem. J., 285, 345-365 (1992).